The National Pharmaceutical Pricing Authority (NPPA) has released a comprehensive notification under Part II, Section 3(ii) of the Gazette of India, revising ceiling prices for over 700 essential medicines. The latest DPCO Price List 2025 will be effective from March 26, 2025, This update…
The world has been dependent on opioids for a long time for pain management, which has driven the search for safer, non‐opioid alternatives. The development of JOURNAVX (Suzetrigine) is not less than a groundbreaking medication approved by the FDA on…
Vitamin B deficiencies are common in India, particularly among vegetarians, elderly patients, and people with chronic conditions like diabetes. Neurobion Forte Tablet is one of the most prescribed B-complex supplements to manage deficiency-related symptoms such as tingling, numbness, fatigue, and…
Living with chronic pain or muscle spasms can feel like carrying a heavy weight every day. Whether it’s osteoarthritis, back pain, or post-injury discomfort, finding effective relief is crucial. Include Aceclofenac, Paracetamol, and Chlorzoxazone tablets i.e. Lace-MR Tablet: a triple-action combo…
The U.S. Food and Drug Administration (FDA) approved Grafapex treosulfan on January 22, 2025, marking a significant advancement in preparative regimens for allogeneic hematopoietic stem cell transplantation (alloHSCT) in patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) 310. Developed by Medac GmbH and…
Breast cancer remains one of the most prevalent and challenging cancers worldwide, with over 300,000 new cases diagnosed annually in the United States alone [4] [10]. Among these, hormone receptor-positive (HR+), and HER2-negative breast cancer accounts for approximately 70% of…
Despite so many sales apps and websites, it is very hard to search pharmaceutical formulation plants for sale in north India or anywhere in India. When we were searching for a plant for us we faced lots of problems finding…
Baddi is India’s pharma hub in terms of manufacturing facilities. According to a news portal survey, there are more than 600 different pharmaceutical manufacturing companies working in the BBN (Baddi, Barotiwala, Nalagarh). Many pharma business owners are in search…
The Indian cough syrup market is booming – estimated at around $330 million in 2024 and growing at about 6–7% annually[1]. Consumers and healthcare professionals alike seek effective, allopathic syrups (non-herbal) to relieve dry coughs, wet (productive) coughs, and pediatric…
Pharma businesses operate in a highly regulated and competitive environment. For investors, wholesalers, and business owners, finding the right partner to navigate the complexities of ownership transitions can make all the difference. Laafon Galaxy Pharmaceuticals has established itself as a…